A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma

Title
A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOTHERAPY
Volume 34, Issue 6, Pages 509-515
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-06-08
DOI
10.1097/cji.0b013e31821dcefd

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More